Milestone Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Milestone Pharmaceuticals has a total shareholder equity of $39.9M and total debt of $50.6M, which brings its debt-to-equity ratio to 126.9%. Its total assets and total liabilities are $96.0M and $56.1M respectively.
Key information
126.9%
Debt to equity ratio
US$50.64m
Debt
| Interest coverage ratio | n/a |
| Cash | US$89.48m |
| Equity | US$39.92m |
| Total liabilities | US$56.08m |
| Total assets | US$96.00m |
Recent financial health updates
Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?
Sep 13
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate
Mar 07We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate
Oct 15We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth
Jun 24We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely
Feb 25We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow
Aug 25Recent updates
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely
Jun 07Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?
Sep 13We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate
Mar 07We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate
Oct 15We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth
Jun 24We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely
Feb 25We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow
Aug 25Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth
Apr 02What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition
Jan 15First patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVT
Nov 18Milestone Pharmaceuticals EPS beats by $0.09
Nov 13Financial Position Analysis
Short Term Liabilities: MIST's short term assets ($94.0M) exceed its short term liabilities ($4.1M).
Long Term Liabilities: MIST's short term assets ($94.0M) exceed its long term liabilities ($52.0M).
Debt to Equity History and Analysis
Debt Level: MIST has more cash than its total debt.
Reducing Debt: MIST's debt to equity ratio has increased from 0% to 126.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MIST has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MIST has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.